Cargando…
Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome
BGP-15 is a new insulin sensitizer drug candidate, which was developed by Hungarian researchers. In recent years, numerous research groups have studied its beneficial effects. It is effective in the treatment of insulin resistance and it has protective effects in Duchenne muscular dystrophy, diastol...
Autores principales: | Pető, Ágota, Kósa, Dóra, Fehér, Pálma, Ujhelyi, Zoltán, Sinka, Dávid, Vecsernyés, Miklós, Szilvássy, Zoltán, Juhász, Béla, Csanádi, Zoltán, Vígh, László, Bácskay, Ildikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024383/ https://www.ncbi.nlm.nih.gov/pubmed/31968693 http://dx.doi.org/10.3390/molecules25020429 |
Ejemplares similares
-
Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect
por: Pető, Ágota, et al.
Publicado: (2021) -
Formulation of Novel Liquid Crystal (LC) Formulations with Skin-Permeation-Enhancing Abilities of Plantago lanceolata (PL) Extract and Their Assessment on HaCaT Cells
por: Kósa, Dóra, et al.
Publicado: (2021) -
Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems
por: Kósa, Dóra, et al.
Publicado: (2021) -
Development and Evaluation of an FDM Printed Nasal Device for CPZ Solid Nanoparticles
por: To Quoc, Thinh, et al.
Publicado: (2023) -
Formulation, Characterization and Permeability Studies of Fenugreek (Trigonella foenum-graecum) Containing Self-Emulsifying Drug Delivery System (SEDDS)
por: Sinka, Dávid, et al.
Publicado: (2022)